Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus
Substantial success has been achieved in the development and implementation of West Nile (WN) vaccines for horses; however, no human WN vaccines are approved. This review focuses on the construction, pre-clinical and clinical characterization of ChimeriVax-WN02 for humans, a live chimeric vaccine co...
Main Authors: | Gustavo H. Dayan, Konstantin Pugachev, Joan Bevilacqua, Jean Lang, Thomas P. Monath |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-12-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/5/12/3048 |
Similar Items
-
Protective Efficacy of a Chimeric Insect-Specific Flavivirus Vaccine against West Nile Virus
by: Laura J. Vet, et al.
Published: (2020-05-01) -
Vaccines in Development against West Nile Virus
by: Frederic Tangy, et al.
Published: (2013-09-01) -
Animal and Human Vaccines against West Nile Virus
by: Juan-Carlos Saiz
Published: (2020-12-01) -
A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
Published: (2015-09-01) -
Twenty Years of Progress Toward West Nile Virus Vaccine Development
by: Jaclyn A. Kaiser, et al.
Published: (2019-09-01)